S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
NYSE:TFX

Teleflex Stock Forecast, Price & News

$305.22
+6.92 (+2.32%)
(As of 12/3/2021 12:00 AM ET)
Add
Compare
Today's Range
$297.44
$306.33
50-Day Range
$289.48
$387.42
52-Week Range
$289.00
$449.38
Volume
565,110 shs
Average Volume
273,838 shs
Market Capitalization
$14.30 billion
P/E Ratio
33.36
Dividend Yield
0.46%
Beta
1.08
30 days | 90 days | 365 days | Advanced Chart
Receive TFX News and Ratings via Email

Sign-up to receive the latest news and ratings for Teleflex and its competitors with MarketBeat's FREE daily newsletter.


Teleflex logo

About Teleflex

Teleflex, Inc. provides medical technology products which enables healthcare providers to improve patient outcomes and enhance patient and provider safety. The firm designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. It operates through the following business segments: Americas, EMEA (Europe, the Middle East and Africa), Asia (Asia Pacific) and OEM. The Americas segment engages in the sales of interventional urology products. The EMEA engages in the sales of urology products. The Asia segment designs, manufactures and distributes medical devices primarily used in critical care, surgical applications and cardiac care and generally serves hospitals and healthcare providers. The OEM segment designs, manufactures and supplies devices and instruments for other medical device manufacturers. The company was founded in 1943 and is headquartered in Wayne, PA.

Headlines

Teleflex (NYSE:TFX) Sets New 1-Year Low at $310.20
November 26, 2021 |  americanbankingnews.com
Teleflex (NYSE:TFX) Hits New 1-Year Low at $325.34
November 19, 2021 |  americanbankingnews.com
See More Headlines

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Sector
Medical
CUSIP
87936910
Employees
14,000
Year Founded
1943

Sales & Book Value

Annual Sales
$2.54 billion
Cash Flow
$14.26 per share
Book Value
$78.08 per share

Profitability

Net Income
$335.32 million
Pretax Margin
17.86%

Debt

Price-To-Earnings

Miscellaneous

Free Float
46,217,000
Market Cap
$14.30 billion
Optionable
Optionable

Company Calendar

Last Earnings
10/28/2021
Ex-Dividend
11/12/2021
Today
12/05/2021
Dividend Payable
12/15/2021
Fiscal Year End
12/31/2021
Next Earnings (Estimated)
2/24/2022

Social Links


MarketRank

Overall MarketRank

2.77 out of 5 stars

Medical Sector

39th out of 1,388 stocks

Surgical & Medical Instruments Industry

6th out of 126 stocks

Analyst Opinion: 3.5Community Rank: 4.1Dividend Strength: 1.7Insider Behavior: 3.3Valuation: 1.3 5 -4 -3 -2 -1 -












Teleflex (NYSE:TFX) Frequently Asked Questions

Is Teleflex a buy right now?

10 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Teleflex in the last year. There are currently 1 hold rating and 9 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Teleflex stock.
View analyst ratings for Teleflex
or view top-rated stocks.

How has Teleflex's stock price been impacted by Coronavirus (COVID-19)?

Teleflex's stock was trading at $342.08 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, TFX stock has decreased by 10.8% and is now trading at $305.22.
View which stocks have been most impacted by COVID-19
.

Are investors shorting Teleflex?

Teleflex saw a increase in short interest in October. As of October 29th, there was short interest totaling 738,700 shares, an increase of 25.8% from the October 14th total of 587,400 shares. Based on an average daily volume of 272,700 shares, the days-to-cover ratio is presently 2.7 days. Approximately 1.6% of the shares of the stock are sold short.
View Teleflex's Short Interest
.

When is Teleflex's next earnings date?

Teleflex is scheduled to release its next quarterly earnings announcement on Thursday, February 24th 2022.
View our earnings forecast for Teleflex
.

How were Teleflex's earnings last quarter?

Teleflex Incorporated (NYSE:TFX) announced its quarterly earnings data on Thursday, October, 28th. The medical technology company reported $3.51 EPS for the quarter, topping analysts' consensus estimates of $3.03 by $0.48. The medical technology company had revenue of $700.25 million for the quarter, compared to analyst estimates of $698.25 million. Teleflex had a net margin of 15.71% and a trailing twelve-month return on equity of 17.78%. The firm's quarterly revenue was up 11.5% on a year-over-year basis. During the same quarter in the prior year, the business earned $2.77 EPS.
View Teleflex's earnings history
.

How often does Teleflex pay dividends? What is the dividend yield for Teleflex?

Teleflex announced a quarterly dividend on Thursday, October 28th. Stockholders of record on Monday, November 15th will be paid a dividend of $0.34 per share on Wednesday, December 15th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.45%. The ex-dividend date of this dividend is Friday, November 12th.
View Teleflex's dividend history
.

Is Teleflex a good dividend stock?

Teleflex pays an annual dividend of $1.36 per share and currently has a dividend yield of 0.46%. The dividend payout ratio of Teleflex is 14.86%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Teleflex will have a dividend payout ratio of 9.51% next year. This indicates that Teleflex will be able to sustain or increase its dividend.
View Teleflex's dividend history.

What guidance has Teleflex issued on next quarter's earnings?

Teleflex issued an update on its FY 2021 earnings guidance on Thursday, November, 4th. The company provided EPS guidance of $13.150-$13.350 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $12.980. The company issued revenue guidance of $2.79 billion-$2.82 billion, compared to the consensus revenue estimate of $2.82 billion.

What price target have analysts set for TFX?

10 brokers have issued 1-year target prices for Teleflex's stock. Their forecasts range from $391.00 to $486.00. On average, they anticipate Teleflex's share price to reach $445.20 in the next twelve months. This suggests a possible upside of 45.9% from the stock's current price.
View analysts' price targets for Teleflex
or view top-rated stocks among Wall Street analysts.

Who are Teleflex's key executives?

Teleflex's management team includes the following people:
  • Liam J. Kelly, Chairman, President & Chief Executive Officer
  • Thomas E. Powell, Chief Financial Officer & Executive Vice President
  • Timothy F. Duffy, Chief Information Officer & Vice President
  • Michelle Fox, Chief Medical Officer & Vice President
  • Gwen Chapman, Chief Compliance Officer & Vice President

What is Liam Kelly's approval rating as Teleflex's CEO?

73 employees have rated Teleflex CEO Liam Kelly on Glassdoor.com. Liam Kelly has an approval rating of 86% among Teleflex's employees.

What other stocks do shareholders of Teleflex own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Teleflex investors own include NVIDIA (NVDA), AbbVie (ABBV), Johnson & Johnson (JNJ), Alibaba Group (BABA), Lam Research (LRCX), ServiceNow (NOW), QUALCOMM (QCOM), Advanced Micro Devices (AMD), salesforce.com (CRM) and Cisco Systems (CSCO).

What is Teleflex's stock symbol?

Teleflex trades on the New York Stock Exchange (NYSE) under the ticker symbol "TFX."

Who are Teleflex's major shareholders?

Teleflex's stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (10.20%), Wellington Management Group LLP (6.97%), American Century Companies Inc. (2.83%), Janus Henderson Group PLC (1.98%), Geode Capital Management LLC (1.75%) and Marshall Wace LLP (1.47%). Company insiders that own Teleflex stock include Andrew A Krakauer, Cameron P Hicks, James J Leyden, John Deren, Liam Kelly, Stephen K MD Klasko and Stuart A Randle.
View institutional ownership trends for Teleflex
.

Which major investors are selling Teleflex stock?

TFX stock was sold by a variety of institutional investors in the last quarter, including Marshall Wace LLP, BlackRock Inc., Invesco Ltd., Janus Henderson Group PLC, Bank of New York Mellon Corp, Allianz Asset Management GmbH, Strs Ohio, and Sectoral Asset Management Inc. Company insiders that have sold Teleflex company stock in the last year include Cameron P Hicks, Liam Kelly, Stephen K MD Klasko, and Stuart A Randle.
View insider buying and selling activity for Teleflex
or view top insider-selling stocks.

Which major investors are buying Teleflex stock?

TFX stock was purchased by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., Wellington Management Group LLP, Moors & Cabot Inc., Sarasin & Partners LLP, NFJ Investment Group LLC, Voloridge Investment Management LLC, Polar Capital Holdings Plc, and Geode Capital Management LLC.
View insider buying and selling activity for Teleflex
or or view top insider-buying stocks.

How do I buy shares of Teleflex?

Shares of TFX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Teleflex's stock price today?

One share of TFX stock can currently be purchased for approximately $305.22.

How much money does Teleflex make?

Teleflex has a market capitalization of $14.30 billion and generates $2.54 billion in revenue each year. The medical technology company earns $335.32 million in net income (profit) each year or $9.15 on an earnings per share basis.

How many employees does Teleflex have?

Teleflex employs 14,000 workers across the globe.

When was Teleflex founded?

Teleflex was founded in 1943.

What is Teleflex's official website?

The official website for Teleflex is www.teleflex.com.

Where are Teleflex's headquarters?

Teleflex is headquartered at 550 E SWEDESFORD RD, WAYNE PA, 19087.

How can I contact Teleflex?

Teleflex's mailing address is 550 E SWEDESFORD RD, WAYNE PA, 19087. The medical technology company can be reached via phone at (610) 225-6800, via email at shareholder[email protected], or via fax at 215-553-5402.


This page was last updated on 12/5/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.